Literature DB >> 200253

Reproducibility of measurements of oestrogen-receptor concentration in breast cancer.

R A Hawkins, A Hill, B Freedman, S M Gore, M M Roberts, A P Forrest.   

Abstract

The reproducibility of measurements of oestrogen-receptor activity has been examined in multiple specimens from a rabbit uterus, a rat mammary tumour and human breast tumours. The relationship between receptor concentration and tumour histology has also been investigated in 11 large primary tumours. In the animal tissues, receptor measurements were relatively reproducible (coefficient of variance: wet wt. basis 16-17%, protein basis 16-21%) but in human breast tumours receptor activity varied considerably (c.v.: wet wt. basis, 22-125%; protein basis, 28-72%). In addition to these variations in receptor activity within tumours, there was a difference between tumours, as demonstrated by an analysis of variance (P less than 0.01). In the 11 primary breast cancers selected for study, the level of receptor activity was related to menopausal status and the tumour content of the specimen. We conclude that the receptor activity detected varies within a tumour and depends upon the tumour content of the biopsy specimen. Predictions based on precise quantitation of receptor concentrations may therefore necessitate replicate tumour sampling and correction for the fraction of non-tumour tissue in each sample.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200253      PMCID: PMC2025411          DOI: 10.1038/bjc.1977.200

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Studies with tritium-labelled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy.

Authors:  P J FOLCA; R F GLASCOCK; W T IRVINE
Journal:  Lancet       Date:  1961-10-07       Impact factor: 79.321

2.  Factors influencing the estimation of oestrogen receptors in human malignant breast tumours.

Authors:  H Braunsberg
Journal:  Eur J Cancer       Date:  1975-07       Impact factor: 9.162

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  Quality control in routine clinical chemistry.

Authors:  L G Whitby; F L Mitchell; D W Moss
Journal:  Adv Clin Chem       Date:  1967       Impact factor: 5.394

5.  Estrogen receptors and breast cancer response to adrenalectomy.

Authors:  E V Jensen; G E Block; S Smith; K Kyser; E R DeSombre
Journal:  Natl Cancer Inst Monogr       Date:  1971-12

6.  Oestrogen receptor activity in human plasma.

Authors:  R A Hawkins; K M Scott; P L Yap
Journal:  Lancet       Date:  1976-12-04       Impact factor: 79.321

7.  Pathological review of breast lesions analyzed for estrogen receptor protein.

Authors:  P P Rosen; C J Menendez-Botet; J S Nisselbaum; J A Urban; V Miké; A Fracchia; M K Schwartz
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

8.  Quantitation of estrogen receptors in human breast cancer by agar gel electrophoresis.

Authors:  F A Teulings; J Blonk-van der Wijst; H Portengen; M S Henkelman; R E Treurniet; H A van Gilse
Journal:  Clin Chim Acta       Date:  1975-10-01       Impact factor: 3.786

9.  A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues.

Authors:  R A Hawkins; A Hill; B Freedman
Journal:  Clin Chim Acta       Date:  1975-10-15       Impact factor: 3.786

  9 in total
  13 in total

1.  Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma.

Authors:  A G Douglas-Jones; N Collett; J M Morgan; B Jasani
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

2.  Oestrogen receptors in human breast cancer. Problems of correlation with histopathological features.

Authors:  H S Poulsen; L Ozzello; J Andersen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

3.  Cellularity and the quantitation of estrogen receptors.

Authors:  R C Mason; R J Steele; R A Hawkins; W R Miller; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

4.  Oestrogen receptor concentration in primary breast cancer and axillary node metastases.

Authors:  R A Hawkins; R Black; R J Steele; J M Dixon; A P Forrest
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

5.  The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.

Authors:  R A Hawkins; K Sangster; A Tesdale; P A Levack; E D Anderson; U Chetty; A P Forrest
Journal:  Br J Cancer       Date:  1988-07       Impact factor: 7.640

6.  Simultaneous micro measurement of steroid receptors in breast cancer.

Authors:  G Milano; J L Moll; J L Formento; M Francoual; B P Krebs; M Namer; J L Boublil; C M Lalanne
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

7.  Histochemical detection of oestrogen receptors in breast carcinoma: a successful technique.

Authors:  R A Hawkins; K Sangster; A Krajewski
Journal:  Br J Cancer       Date:  1986-03       Impact factor: 7.640

8.  Variations in steroid receptors and cyclic AMP binding proteins across human breast cancers: evidence for heterogeneity.

Authors:  R O Senbanjo; W R Miller; R A Hawkins
Journal:  Br J Cancer       Date:  1986-07       Impact factor: 7.640

9.  Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?

Authors:  R A Hawkins; A L Tesdale; E D Anderson; P A Levack; U Chetty; A P Forrest
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

10.  Cyclic AMP binding proteins in human breast cancer.

Authors:  W R Miller; R O Senbanjo; J Telford; D M Watson
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.